{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-020776","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.911772+00:00","generated_at":"2026-06-05T01:53:52.272305+00:00","sec_items":["3.01","5.02","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elevai Labs receives Nasdaq bid price deficiency notice; director resigns, Kovalyov appointed","bullets":["Received Nasdaq notice March 6, 2024: bid price below $1.00 for 30 consecutive days; 180-day compliance period until Sept 3, 2024.","Director Crystal Muilenburg resigned effective March 1, 2024, no disagreement; cited limited availability.","George Kovalyov appointed as independent director, audit/nomination committee member, compensation committee chair; granted 80,000 stock options at $1.00/share, 4-year vest.","Kovalyov receives $500 per virtual board meeting and additional $500 for in-person attendance.","Company intends to monitor bid price and consider options to regain compliance; no immediate delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-020776","json":"https://secwatch.observer/filing/0001213900-24-020776.json","markdown":"https://secwatch.observer/filing/0001213900-24-020776.md","text":"https://secwatch.observer/filing/0001213900-24-020776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024020776/0001213900-24-020776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024020776/ea0201328-8k_elevailabs.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:53:52.272305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0112567de42d3610128851386be350796241a82c","claim":"PMGC Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).","evidence_excerpt":"March 6, 2024, Elevai Labs Inc. (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq ”) notifying the Company that, based on the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimu","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024020776/0001213900-24-020776-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"135f394cee","claim":"George Kovalyov was appointed as Director at PMGC Holdings Inc..","evidence_excerpt":"the Board appointed Mr. George Kovalyov, as independent director of the Company, as a member of the audit and nomination committee of the Board, and as chairman to the Compensation Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024020776/0001213900-24-020776-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ce429974b5","claim":"Crystal Muilenburg resigned as Director at PMGC Holdings Inc..","evidence_excerpt":"On March 1, 2024, Ms. Crystal Muilenburg, an independent director of the Company notified the board of directors of the Company (the “Board”) of her intention to resign as a director and as chair of the compensation committee of the Company (the “Compensation Committee”) and as a member of the nominating and audit committees of the Company , effective on March 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840563/000121390024020776/0001213900-24-020776-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}